CME and CFTC Clash Over On-Chain Perpetual Futures

The Commodity Futures Trading Commission's recent approval of crypto perpetual futures has sparked a heated battle with the CME Group, the largest derivatives exchange operator in the US. The CME has filed a lawsuit against the CFTC, arguing that the regulator is mislabeling these products and misapplying the law. The dispute centers on the definition of a swap and whether perpetual futures, which allow users to speculate on the price of an asset with leverage and no expiration date, should be classified as such. The CME claims that these products are harmful to its traditional futures contracts and that the CFTC's sudden embrace of them did not consider the ramifications. The CFTC, on the other hand, is seeking to open up the US market to these products, with Chairman Mike Selig signing off on a Kalshi product and approving customer activity at Coinbase. The outcome of this dispute could have significant implications for the rapidly growing arena of perpetual futures, with non-US volume reportedly reaching $60 trillion last year. The CME's lawsuit argues that the CFTC's decision to allow these products was made without proper consideration of the law and the potential consequences. The regulator's approach has been criticized by some as being too hasty and not providing enough opportunity for public comment. The dispute has also sparked a debate about the role of regulation in the crypto space, with some arguing that the CME is using regulation to stifle competition and innovation. As the case makes its way through the federal court, the future of CFTC-driven perps remains uncertain, with the CME preparing its case and the regulator facing criticism for its approach to regulating these products.